Edith Borcoman

Also affiliated with International Drug Development, Institut Curie

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial”.

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial

Nature Cancer(2025)10.1038/s43018-025-01004-2

N/A

0.241DataRank · unranked

4 citations

Bastien Cabarrou, Miguel Francisco, Frédéric Bigot, François Ghiringhelli, Damien Vansteene +37 more

CD39 + conventional CD4 + T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade

OncoImmunology(2023)10.1080/2162402x.2023.2246319

N/A

0DataRank · unranked

17 citations

Carolina Abrate, Jimena Tosello, Constanza Rodríguez, Fernando P. Canale, María C. Ramello +13 more